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Investigating the role of drugs whose pharmaceutical activity is associated with cell membranes is fun-
damental to comprehending the biochemical processes that occur on membrane surfaces. In this work,
we examined the action of 1,4-naphthoquinone in lipid Langmuir monolayers at the air–water interface,
which served as a model for half of a membrane, and investigated the molecular interactions involved
with tensiometry and vibrational spectroscopy. The surface pressure–area isotherms exhibited a notice-
able shift to a lower area in relation to 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-
dihexadecanoyl-sn-glycero-3-phospho-L-serine (DPPS) lipid monolayers, which indicated a disruption
of the monolayer structure and solubilisation of the lipids towards the aqueous subphase. To better cor-
relate to the action of this drug in biological membrane events, cell cultures that represented tumorigenic
and non-tumorigenic cells were spread onto the air–water interface, and 1,4-naphthoquinone was then
incorporated. While only slight changes were observed in the non-tumorigenic cells upon drug incorpo-
ration, signiﬁcant changes were observed in the tumorigenic cells, on which the organisation of the Lang-
muir monolayers was disrupted as evidenced by tensiometry and vibrational spectroscopy. This work
then shows that this drug interacts preferentially for speciﬁc surfaces. In simpliﬁed models, it has a
higher effect for the negative charged DPPS rather than the zwitterionic DPPC; and for complex cell cul-
tures, 1,4-naphthoquinone presents a more signiﬁcant effect for that representing tumorigenic cells.
 2013 Elsevier Inc. All rights reserved.1. Introduction
The actions of drugs in cell membranes involve mechanisms
that include interactions at a molecular level, which are not well
understood. Among these drugs, naphthoquinones are organic
molecules that form the main chemical structures of several natu-
ral compounds such as vitamin K. Some naphthoquinone deriva-
tives reportedly have pharmacological properties presenting
cytotoxicity. Many are considered antimicrobial [1,2] (antibacte-
rial, antiviral, antifungal) and insecticidal [3], and others present
antipyretic and anti-inﬂammatory properties [4]. The action of
naphthoquinones as anti-cancer agents has been reported [5,6],
with potential activity as cell membrane (tumorigenic or healthy)
disruptors. In particular, 1,4-naphthoquinone is present in various
chemotherapeutic mixtures [5]. This drug is a potent cell growth
and tumour angiogenesis inhibitor [7], but little is currently known
about the molecular mechanism of action of this drug when it
interacts with cell membranes.
Given this lack of knowledge, the present work aims to
understand the drug–cell interactions at the molecular andll rights reserved.cellular levels using Langmuir monolayers as cell membrane
models. The Langmuir monolayer is a system recognised as able
to mimic half of a membrane [8], and basically consists of stable
monomolecular-thick ﬁlms formed when an amphiphile is
spread on the top of the air–water interface [9]. Lipids are fre-
quently employed as primary material used to produce such
ﬁlms and are subsequently employed for detailed investigations
of the interactions between membrane proteins [10,11], enzymes
[12], ions [13], polysaccharides [14], nucleic acid based-com-
pounds [15] and synthetic polymers [16]. Although the use of
proteins that interact with only one side of the membrane, such
as GPIs, has already been investigated [10], interest is growing in
the study of proteins that interact with both sides of the mem-
brane, such as transmembrane proteins [17].
In this paper, the action of a antineoplasic drug, 1,4-naphtho-
quinone, is investigated at the molecular level in model membrane
systems consisting of lipid monolayers. This technique has been
demonstrated as a potent tool for detailed investigations of molec-
ular mechanisms in simple model systems in which the composi-
tion, surface pressure and surface rheological properties can be
highly controlled. Some additional experiments have been carried
out with cell cultures—tumorigenic or healthy—to better under-
stand to the action of this drug as an anticancer agent.
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Fig. 1. Surface pressure–area isotherms for the DPPC, pure or mixed with 1,4-
naphthoquinone in the quantities indicated in the inset.
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2.1. Materials
The 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and
1,2-dihexadecanoyl-sn-glycero-3-phospho-L-serine (DPPS) sodium
salt were purchased from Sigma–Aldrich (St. Louis, MO, USA) and
dissolved in chloroform (Synth, Diadema, Brazil) to a concentration
of 0.5 mg/mL. The monolayer subphase approximated physiologi-
cal conditions and consisted of a 50 mM phosphate buffer and
150 mM NaCl at a pH of 7.4. The water employed was puriﬁed
using a MilliQ-Plus System (resistivity 18.2 MX cm, pH 5.5).
2.2. Cell culture
An endothelial cell line derived from rabbit aorta (EC) [18]
transfected with an EJ-ras oncogene (EJ-ras EC) [19] was grown
in F-12 medium (Gibco BRL, Grand Island, USA) supplemented with
10% fetal calf serum (FCS) (Cultilab, Campinas, SP, Brazil) in the
presence of penicillin (100 U/mL) and streptomycin (100 lg/ml).
The cell lines were grown at 37 C in a humidiﬁed, 2.5% CO2 atmo-
sphere and sub-cultured every week with pancreatin (Sigma–
Aldrich, St. Louis, MO, USA).
2.3. Cell extract
The cells were maintained in culture at 37 C in a humidiﬁed,
2.5% CO2 atmosphere for 1 week. Then, the culture mediumwas re-
moved, and the cells were washed twice with F-12 medium and re-
moved from the dish with 3.5 M urea in 25 mM Tris–HCl (pH 7.8)
to obtain the cell extract.
2.4. Langmuir monolayers
The Langmuir monolayers were obtained by spreading a chloro-
form solution of DPPC, DPPS, or cell cultures on the surface of an
aqueous buffer solution. The surface pressure–area (p–A) iso-
therms were obtained in a mini-KSV Langmuir trough equipped
with a surface pressure sensor (the Wilhelmy method), with an
interface compression rate of 5 Å2 molecule1 min1. For mixed
drug–lipid monolayers, ﬁrst 1,4-naphthoquinone, dissolved in
chloroform in a concentration of 1.04 mg/mL, was deposited on
the air–water interface. DPPC or DPPS, dissolved in chloroform,
was further spread. After allowing the chloroform to evaporate
for 20 min. (and absence of this solvent attested with vibrational
spectroscopy), the DPPC or DPPS monolayer was compressed to a
surface pressure of 30 mN/m. This surface pressure was chosen be-
cause it corresponds to the lateral surface pressure of the mem-
brane [20]. For the aqueous suspension extracts, they were
spread after drug deposition and chloroform evaporation. It is
important to emphasise that by using these procedures there
was no contact of the cell extract with the solvent. The system
was then allowed to stabilise for 1 h after the surface pressure of
30 mN/m has been reached. The stabilisation was conﬁrmed using
Polarisation-Modulation Infrared Reﬂection–Absorption Spectros-
copy (PM-IRRAS) spectroscopy until no variation in the signal
was detected. The surface pressure was maintained at 30 mN/m
by moving the barriers, and the stabilisation of the monolayer
was monitored until no additional movement of the barriers was
needed. The PM-IRRAS measurements were taken using a KSV
PMI 550 instrument (KSV Instruments, Ltd., Helsinki, Finland) at
a ﬁxed incidence angle of 75. The surface pressure–area isotherms
were obtained to evaluate the manner in which the drug shifts the
monolayer to large areas and to investigate the mixed monolayer
in the 2-D states achievable by the monolayer from the expandedphases to the collapse. Thus, the monolayer was expanded to the
maximum area allowed for the Langmuir trough and then com-
pressed until its collapse. All experiments were carried out at a
controlled room temperature (25 C).3. Results and discussion
3.1. DPPC monolayers
First, it is important to emphasise that pure 1,4-naphthoqui-
none when spread alone at the air–water interface does not form
regular Langmuir monolayers, forming spots that are not able to
spread uniformly along the surface. Therefore, all the studies ex-
posed here show the interaction of this compound mixed with lip-
ids or cell cultures. In fact, this is the ﬁrst evidence that 1,4-
naphthoquinone has surface activity enhanced with the presence
of cell membrane lipids.
The effect of 1,4-naphthoquinone on a DPPC monolayer was
investigated using surface pressure–area isotherms (Fig. 1). Pure
DPPC presented a typical curve with a transition between the li-
quid-expanded and liquid-condensed states as represented by a
plateau at approximately 95 and 70 Å2 molecule1 and at a surface
pressure of approximately 5 mN/m.
First of all, it is important to emphasise that by mixing lipids
and drug in the same solution, prior to the spreading on the air–
water interface, the same results are obtained, indicating that we
are working in the equilibrium regime. In view of that, to obtain
the sequential surface pressure–area isotherms, ﬁrst the drug
was deposited, and after was the lipid solution. This kind of proce-
dure was carried out because we intended to compare with the
sequential results obtained when the cell cultures were spread, in-
stead of the pure lipids. As for the last case we did not wanted the
presence of chloroform, it was necessary to spread ﬁrst the drug
and then wait for chloroform evaporation.
The incorporation of small quantities of 1,4-naphthoquinone
shifted the curve to lower DPPC molecular areas. This effect is usu-
ally attributed to the condensation of the lipid monolayer due to
the stabilisation of the lateral repulsion between the chains. This
phenomenon is common, especially when treating charged lipids
with ions [13]. However, in this case, monolayer condensation is
unlikely, not only because the DPPC is zwitterionic and the charge
effects must be reduced, but also because the shift to the lower
areas was too large to simply be attributed to a condensation ef-
fect. For example, the isotherm shifted from 51 Å2 for pure DPPC
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rated drug. This effect could be therefore attributed to the destabil-
isation of the drug caused by the drug itself, which led to either the
solubilisation of the drug in the aqueous subphase or the formation
of collapsed-like structures. Such effect is corroborated by the ki-
netic adsorption data provided in Fig. 2, which shows the increase
in the surface area of a pre-formed and compressed monolayer
after drug incorporation. However, we must to emphasise that
the experiments are different. For the surface pressure–area iso-
therms, the drug is incorporated as a mixed monolayer at low sur-
face pressures and compressed together the lipids until the desired
surface pressure. For the kinetic curves, the drug is tried to be
incorporated in a pre-formed and well-packed lipid monolayer, al-
ready in a pre-determined surface pressure. Consequently the ef-
fects should be different. For instance, in the surface pressure of
30 mN/m, since the surface packing is higher, the drug has more
difﬁcult to be incorporated, and the increase in surface area should
be lower. This result is signiﬁcant because it showed that even for
this case, the drug is able to destabilize the membrane and cause
some decrease in the surface pressure, corroborating to the effect
observed when the drug is incorporated at lower surface pressures.
With increasing quantities of 1,4-naphthoquinone incorpo-
rated, the isotherms (Fig. 1) are shifted to lower areas as predicted.
It is important to emphasise that the X-axis considered is the aver-
age area available for all molecules present at the interface (lipid
and the drug). Lower quantities of the drug were also tested, and
up to 0.5%, and the effect was similar to that for 5% of the drug.
At even lower quantities, no effect was observed in the isotherm.
Therefore, the range of tractability for the destabilising effect was
as low as 0.5%.
Again, one must emphasise that when only the drug is spread at
the air–water interface and is compressed to the end, no observa-
ble increase occurs in the surface pressure. This fact is associated
with the fact that the drug could not be dispersed uniformly on
the air–water interface after the spreading of its solution on the
water surface, which reﬂects the low spreading capability. There-
fore, the presence of DPPC at the air–water interface facilitates
the homogeneous dispersion of the drug along the surface.
Furthermore, one must emphasise that the plateau, which char-
acterises the phase transition at approximately 5 mN/m, becomes
less evident as higher concentrations of the 1,4-naphthoquinone
are inserted. In addition, the slope for increased surface pressures
(above 10 mN/m) becomes progressively less angled. Both phe-
nomena are consequences of the component mixture that affects
the rheological properties of the lipid monolayer. The slope is al-
tered as the compressibility of the monolayer surface changes,0 10 20 30 40 50 60 70 80
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Fig. 2. Adsorption kinetics (area change DA versus time) for 1,4-naphthoquinone
(5% in mol) injected below a stable DPPC monolayer at constant surface pressures
(values indicated in the inset).i.e., the monolayer becomes more compressible with the addition
of the drug. This is commonly attributed in the literature to an ef-
fect of the lateral ﬂuidisation of the monolayer as a new compo-
nent prevents the lipids from attaining a well-packed structure
[21]. The so-called in-plane elasticity (E) can be calculated as A
(op/oA), in which A is the molecular area, and p is the surface pres-
sure. Table 1 summarises these data and indicates that increasing
the quantity of 1,4-naphthoquinone progressively decreases the
monolayer’s in-plane elasticity. The data are shown for 30 mN/m,
which corresponds to the lateral pressure of a biological membrane
[20]. The reduction of in the in-plane elasticity is interesting be-
cause indicates that the drug at the interface causes a disruption
of the order of the packed lipid monolayer. This fact can be then re-
lated to the introduction of a new component interacting with the
hydrophobic and hydrophilic parts of the lipid.
Then, we can presume a model of interaction between the drug
and the phospholipid in which the carbonyl groups of 1,4-naphtho-
quinone may interact preferentially with the polar head of the
phospholipid, while some of the hydrophobic groups of the aro-
matic ring of the drug may interact with the alkyl chains of the li-
pid. More details about such interaction could be obtained if
vibrational spectroscopy is employed, as shown in the next
paragraphs.
Fig. 3 provides the PM-IRRAS spectra for the monolayer. Panel A
presents the region of CAH stretches in CH2. The band at
2852 cm1 is ascribed to the symmetric stretching, and the one
at 2913 cm1 is ascribed to the asymmetric stretching. With drug
incorporation, an inversion of the relative intensities occurs be-
tween the symmetric and asymmetric bands, shifting from 0.85
for pure DPPC to 1.16, for drug-incorporated DPPC. This effect
may be due to the disorder caused by the drug. Panel B primarily
shows the region of the hydrophilic moiety in the DPPC. The band
at 1741 cm1 is attributed to the C@O stretch from the phospho-
lipid and does not signiﬁcantly change upon drug incorporation.
The three bands whose central band is at 1676 cm1 are attributed
to the surface water bending, and with drug incorporation, may
overlap the carbonyl stretching in the 1,4-naphthoquinone, which
occurs at 1690 cm1 [22]. The primary change occurs in the band
at 1268 cm1, which is attributed to phosphate stretching, which
disappears with drug incorporation. In addition, a small band at
1062 cm1 appears with 1,4-naphthoquinone incorporation and
is attributed to the CAH in-plane bands in the aromatic drug com-
pounds, indicating their likely presence at the interface.3.2. DPPS
Many cancerous cells reportedly contain excess lipids with ser-
ine heads [23]. Several studies have revealed a high frequency of
apoptosis in spontaneously regressing tumours and tumours trea-
ted with cytotoxic anticancer agents [24]. Changes on the surfaces
of apoptotic cells, such as exposure to phosphatidylserine, have
been identiﬁed [25]. Phosphatidylserine lipids are negatively
charged and normally dominate the membrane leaﬂets facing the
cytosol [26]. The surface exposure of the PS lipids has beenTable 1
In-plane elasticity for the DPPC monolayers (pure or mixed) at 30 mN/m.
Monolayer E (mN/m)
DPPC 235
DPPC + 5% 1,4-naphthoquinone 106
DPPC + 10% 1,4-naphthoquinone 83
DPPC + 20% 1,4-naphthoquinone 73
DPPC + 30% 1,4-naphthoquinone 61
DPPC + 50% 1,4-naphthoquinone 59
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Fig. 3. PM-IRRAS spectra for the DPPC, pure or mixed with 1,4-naphthoquinone (5%
in mol). Panel A: CAH stretching regions; Panel B: amide and phosphate regions.
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Fig. 4. Surface pressure–area isotherms for DPPS, pure or mixed with 1,4-
naphthoquinone in the quantities indicated in the inset.
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Fig. 5. Adsorption kinetics (area change DA versus time) for 1,4-naphthoquinone
(5% in mol) injected below a stable DPPS monolayer at constant surface pressures
(values indicated in the inset).
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and the cells have been shown to undergo apoptosis to break up
the phospholipid asymmetry of their plasma membranes [25]
and expose the PS. Thus, we employed DPPS as model for tumori-
genic cells. Fig. 4 provides the surface pressure–area isotherms.
Basically, the presence of 1,4-naphthoquinone shifts the isotherm
to lower areas. However, with increasing drug concentrations,
the curves progressively shift to lower areas. The mechanism of
the monolayer collapse also changes signiﬁcantly. With the DPPS,
the increase in the compressibility at approximately 50 mN/m ini-
tially signals the formation of the disordered multilayer structures,
and a constant surface pressure begins only at 60 mN/m. With the
drug, possibly due to the likely solubilisation of the lipid in the
aqueous subphase, the monolayer is in a less compressible state
until the surface pressure reaches approximately 60 mN/m, which
may be associated with the fact that in the presence of the drug
with its destabilising effect on the ﬁlm, the phospholipid molecules
have another way to molecularly readapt under compression; in-
stead of collapsing, the monolayers move toward the aqueous sub-
phase that is subjected to solubilisation with the drug.
This fact is corroborated by the data in Fig. 5, which demon-
strates that the surface pressure decreases after the introduction
of the drug in a constant area regime. The data on (Table 2) indicate
that the surface elasticity values decrease only slightly with up to
30% 1,4-naphthoquinone, but with 50% of the drug, the monolayer
becomes signiﬁcantly more compressible.
The PM-IRRAS spectra (Fig. 6) exhibit no signiﬁcant change in
the hydrophobic region. However, substantial changes are noted
in the hydrophilic region. A signiﬁcant negative band is observed
at 1678 cm1 indicating surface water vibrations. Another bandat 1527 cm1 [28] is related to interfacial water, which is report-
edly to be orientated in such a way that the oxygen is exposed to
the air phase. The dipole is then disposed so that the largest posi-
tive charge is orientated toward the aqueous phase. This fact is
usually corroborated with the surface potential measurements
[29], which exhibit a negative surface potential for the surface of
pure water. Upon introduction of the DPPS, the water molecules
on the surface may contact a negative charge from the phospho-
lipid, which inverts the position of the dipole in the water mole-
cules and is associated with the negative band in the PM-IRRAS
[28]. Additionally, the absence of water molecules provides the dif-
ference in reﬂectivity between the surface covered with the lipid
monolayer and the surface that is not covered to yield the given
spectra [28].
Interestingly, after 1 h with naphthoquinone, these bands dis-
appear. The phosphate stretching band at 1250 cm1 also disap-
pears, and the bands at 1120 and 1211 cm1, attributed to the
drug, are evident in the spectra. The band in 1461 cm1 and in
1653 cm1 indicates the vibration of CAH and carbonyl from 1,4-
naphthoquinone. In addition the band characteristic of carbonyl
stretching becomes more evident at 1700 cm1. These results
provide clear evidence that the drug acts strongly with the polar
heads of the negatively charged lipids with little effect on
the hydrophobic chains. This could indicate that the drug acts
Table 2
In-plane elasticity of the DPPS monolayers (pure or mixed) at 30 mN/m.
Monolayer E (mN/m)
DPPS 195
DPPS + 5% 1,4-naphthoquinone 181
DPPS + 10% 1,4-naphthoquinone 173
DPPS + 20% 1,4-naphthoquinone 167
DPPS + 30% 1,4-naphthoquinone 165
DPPS + 50% 1,4-naphthoquinone 89
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Fig. 6. PM-IRRAS spectra for the DPPS, pure or mixed with 1,4-naphthoquinone (5%
in mol). Panel A: CAH stretching regions; Panel B: phosphate regions.
25
30
35
re
 (m
N
/m
)
 Culture for non-tumorigenic cells
 Culture for non-tumorigenic cells + drug
304 N. Hussein et al. / Journal of Colloid and Interface Science 402 (2013) 300–30640 80 120 160 200 240 280
0
5
10
15
20
Su
rf
ac
e 
Pr
es
su
Surface Area
Fig. 7. Surface pressure–area isotherms for cultures of non-tumorigenic cells, pure
or mixed with 1,4-naphthoquinone (5% in mol). For comparison, the molecular area
displayed is that on which the DPPC or DPPG was spread.preferentially on the surface of the negatively charged lipids, and
this fact could be related to the destabilising effect on the mem-
branes. Thus far, the 1,4-naphthoquinone appears to act in both
DPPC, used herein as a model for healthy membranes, and DPPS,
which may serve as a model for cancerous cells. However, the ef-
fects with DPPS are more evident, especially if we analyse the
PM-IRRAS spectra. Drugs that act on cells typically ﬁrst attack
the external surfaces, which may expose the hydrophilic heads.
Several cells present primarily zwitterionic heads, but in tumori-
genic cells, the quantity of negatively charged lipids increases dis-
proportionally [23].
To better correlate the differences in the actions of such drugs in
healthy and sick cells, we used cell cultures from tumorigenic and
normal cells.3.3. Cell cultures
Because a cell culture may present multiple components, distin-
guishing the role of each one may prove difﬁcult. For this distinc-
tion, a correlation using a simpliﬁed model for the cell
membrane presented in the previous sections is necessary and
can provide relevant information. Wild-type cells, representing
non-tumorigenic cells, and cells transfected with the EJ-ras onco-
gene (tumorigenic cells) were utilised. Then it is important to
emphasise that as we are treating with lipids at the surface, we
are here not focusing on the living cell, but obtaining information
from a cell membrane model, represented by a complex Langmuir
monolayer, which contains not only lipids, but also all other com-
ponents present in the culture. Considering the complexity to ana-
lyse results from systems like that, they were then compared with
simpler models for cell membranes, represented by pure lipid
(DPPC or DPPS) monolayers. In this strategy, it was possible to con-
nect a simple model, in which speciﬁc interactions can be detected,
with a complex, but more realistic, model. By linking the results
obtained from these models, broader insights may be then
acquired.
Fig. 7 indicates that for the culture considered normal, the drug
has little effect on the isotherm. Apparently the drugs decrease the
surface pressure for the large areas, and for the relevant surface
pressure (30 mN/m), the isotherms appear nearly coincident. The
curve does not exhibit any noticeable phase transition due to the
high ﬂuidity of the layer, which may consist of a mixture of com-
ponents, proteins and glycoproteins that can ﬂuidise the
monolayer.
The PM-IRRAS spectra (Fig. 8) also exhibit few changes. In par-
ticular, a strong positive band for water can be found in the hydro-
philic region (Panel B), indicating that the absorption of water
molecules with the cell culture could be due to the presence of gly-
cidic chains, which have a high afﬁnity for water. Bands for the gly-
cidic chains appear at 1223 and 1122 cm1, and a phosphate band
appears at 1266 cm1. These bands are little affected by the drug.
For the tumorigenic cells, however, the effect of the drug is
more pronounced. The isotherms (Fig. 9) exhibit a signiﬁcant de-
crease in the surface pressure, as observed for the pure lipid mon-
olayers. The PM-IRRAS spectra also exhibit signiﬁcant changes,
even in the CAH stretching (Fig. 10). The region of 1400–
1700 cm1, for example, changes signiﬁcantly, which corroborates
the allegation that this drug has a more signiﬁcant effect on
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Fig. 8. PM-IRRAS spectra for non-tumorigenic cells, pure or mixed with cultures of
non-tumorigenic cells. Panel A: CAH stretching regions; Panel B: phosphate
regions.
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in these spectra is high since the cell cultures present a high
amount of substances, and they must provide a non-ordered struc-
ture at the interface. Many chemical groups can contribute for the
bands shown in the spectra. However we can observe some
remarkable changes with drug incorporation. The band in
2869 cm1 is split in two bands: one in 2893 cm1 and the other
one in 2862 cm1. Also, the band in 2893 cm1 becomes a shoulder
after incorporation of 1,4-naphthoquinone. Also the ratio between
the intensities of the bands in 2937 and 2962 cm1 changes from
1.7 to 0.85. In the region of 1000–1800 cm1 the spectra seem
quite noisy, which can be ascribed to the presence of a great
amount of proteins and polysaccharides, whose main vibration
groups are active in this region. For instance, the band in
1243 cm1 is not altered, but the band in 1106 cm1 increases rel-
atively its intensity in relation to the previous one. Both bands are
probably attributed to ether vibrations present in polysaccharides.
Also the band in 1656 cm1, attributed to amide I vibration in pro-
teins, becomes better deﬁned with 1,4-naphthoquinone incorpora-
tion. Comparing the spectrum from Panel 10A with that one from
Panel 10B, it seems that the effect is more pronounced for the alkyl
vibrations region, which may be associated to high hydrophobicity
of this drug. One of the main actions of 1,4-naphthoquninone may
be associated with its interaction with the molecules from the cell
culture that remains at the air–water interface, on which may al-
ters the organisation of the lipids from the cell culture present atthe surface. These molecules are expected therefore to have a more
hydrophobic characteristic since they present the highest surface
activities from the molecules present the extracts.
306 N. Hussein et al. / Journal of Colloid and Interface Science 402 (2013) 300–306The results therefore indicate that in the presence of the drug,
the properties of the healthy cell monolayer model were not signif-
icantly altered; therefore, the healthy cells appeared resistant to
the action of the 1,4-naphthoquinone. However, for the tumori-
genic cell monolayer model, the monolayer collapsed as the iso-
therms shifted to lower regions, and the vibrational spectroscopy
indicated molecular disorganisation at the surface. This result
could be related to the fact that cancerous cells are reportedly
resistant to apoptosis [30]. Therefore, the discovery of drugs that
can induce a disruption in the cell membrane and cellular death
is of great interest.
4. Conclusions
This paper shows that 1,4-naphthoquinone can be incorporated
into a simpliﬁed model of the cell membrane outer layer at an air–
water interface in a proof-of-concept experiment. The effects of the
drug were observed on tumorigenic cells, and zwitterionic and
negatively charged lipids, on which part of the monolayer was ﬂu-
idised due to the molecular disorganisation caused by the drug. A
smaller effect was observed in cell models considered normal, indi-
cating that the drug could differentiate between ﬁlms with speciﬁc
compositions at the air–water interface. In conclusion, we believe
that these results could have a signiﬁcant impact on the under-
standing of the interaction between 1,4-naphthoquinone and cell
membrane surfaces during biochemical processes.
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